David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,710
Out of 5,115 analysts
8
Total ratings
11.11%
Success rate
-46.79%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $1.22 | +473.77% | 3 | Oct 8, 2025 | |
| AEON AEON Biopharma | Reiterates: Buy | $7.2 | $1.16 | +520.69% | 1 | Oct 8, 2025 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $2.07 | +5,101,349.28% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $0.75 | +1,633.33% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $1.07 | +11,208.41% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $1.22
Upside: +473.77%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $1.16
Upside: +520.69%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $2.07
Upside: +5,101,349.28%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $0.75
Upside: +1,633.33%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.07
Upside: +11,208.41%